Abstracts

620 – No Impact on the CNS After Switching to Dolutegravir/Lamivudine From a 3-Drug Regimen

Background Dual-drug therapy with dolutegravir/lamivudine (DTG/3TC) is effective in achieving viral suppression in the blood, but its impact on HIV infection in the central nervous system (CNS) remains insufficiently explored. In this study, we aimed to investigate its effect in the CNS through assessment of cerebrospinal fluid (CSF) in individuals switching to DTG/3TC from a…

625 – Number and Effectiveness of Antihypertensives Are Associated With Cognitive Performance in PWH

Background People with HIV (PWH) experience age-related health problems, including cardiovascular disease and cognitive decline. Some medications used to treat hypertension exhibit anticholinergic properties. This study investigated the effects of cognitive performance on antihypertensive use and mean arterial pressure (MAP) in hypertensive PWH and people without HIV (PWoH), focusing on whether worsening cognitive function influenced…

602 – Higher suPAR Relates to Domain-Specific Cognitive Function in Virally Suppressed Women With HIV

Background Chronic inflammation plays a role in cognitive function in people with HIV (PWH). Soluble Urokinase Plasminogen Activator (suPAR) is a biomarker of chronic inflammation previously associated with cognitive impairment in a small study of men with HIV. Our study aimed to examine whether elevated suPAR levels are associated with domain-specific cognitive function in virally…

619 – Cognitive and Sensorimotor Difficulties in Well-Controlled People With HIV Living in Uganda

Background Individual differences in early life experiences (e.g., trauma), behaviors (e.g., substance use), the immune response of the body-brain, and HIV treatment contribute to a range of brain health complications (BHCs) in people with HIV (PWH). In sub-Saharan Africa, particularly in Rakai, Uganda, these individual factors are often less pronounced; substance use is low, and ART…

603 – Cognitive Intra-Individual Variability Predicts IADL Function in the Women’s Interagency HIV Study

Background Cognitive intra-individual variability (IIV) refers to the variation observed in cognitive performance when various cognitive tests are administered within the same person (i.e., dispersion). In people with HIV, greater cognitive IIV has been associated with poorer cognitive performance and decline over time, cortical brain atrophy, and increased mortality risk. In this study, we calculated…

588 – Association of CSF Viral Compartmentalization and Macrophage Tropism With Neurosymptomatic HIV

Background HIV-1 can be detected in cerebrospinal fluid (CSF) throughout untreated infection but it is unknown how often this is due to local replication in the CNS. In people with HIV-associated dementia (HAD), local replication can generate genetically distinct viral populations in the CNS (compartmentalized) with the unique ability to efficiently infect myeloid lineage cells…

622 – Greater Cognitive Decline in Cognitively Unimpaired Older Thai PWH at Baseline

Background Cognitive impairment remains a crucial health issue among people with HIV (PWH). However, the course of cognitive impairment has shifted considerably since the introduction of combined antiretroviral therapy. We aimed to determine the differences in cognitive decline between PWH with and without cognitive impairment at baseline in a cohort of virologically suppressed older PWH. Methods Virologically…